Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan’s Gunze Expects To Market Artificial Skin In Europe Within Year

This article was originally published in PharmAsia News

Executive Summary

Within the coming year, Japanese firm Gunze expects to begin marketing its Pelnac artificial skin in Europe to treat burns, bedsores and other types of wounds. Pelnac is a collagen sponge that serves as a skin until natural skin grows back into place. Gunze already markets the product in Japan and China through other companies. Pelnac is not yet approved for use in Europe, but the company expects approval during fiscal 2008. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts